REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Max Bdc, S.R.O. (Czech Republic)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Dr. Max Bdc, S.R.O. Profile Updated: October 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Dr.Max Pharmacy Chain is an omnichannel pharmacy chain in Central Europe. The company operates in 6 countries and offers a wide range of pharmaceutical products exclusively in their pharmacies, including licensed and non-licensed products. Dr.Max aims to improve healthcare by providing access to a broad assortment of medicines and pharmacy services. The company also has a pharma wholesale division and a marketing & sales division. With a consolidated revenue of over 4.5bnEUR, Dr.Max is fully owned by Penta Investments and is focused on digitalization and e-commerce to provide a digital experience to their customers.

Headquarters
Na Florenci 2116/15
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Dr. Max Bdc, S.R.O. report to view the information.

Website: http://www.drmax.eu

Basic Information
Total Employees:
Purchase the Dr. Max Bdc, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Dr. Max Bdc, S.R.O. report to view the information.
Registered Capital:
Purchase the Dr. Max Bdc, S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr. Max Bdc, S.R.O. report to view the information.
Incorporation Date:
November 19, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr. Max Bdc, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
25.36%
Total operating revenue
25.22%
Operating profit (EBIT)
190.65%
EBITDA
32.99%
Net Profit (Loss) for the Period
N/A
Total assets
2.4%
Total equity
3.79%
Operating Profit Margin (ROS)
10.45%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-6.72%
Quick Ratio
0.62%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?